FABP4 and atrial fibrillation: A study by González-Ferrero et al.42 measured galectin-3, fatty acid-binding protein-4 (FABP4), and soluble receptor for advanced glycation end products (sRAGE) and found no differences in biomarker levels between individuals with AF alone and those with concomitant heart failure.